期刊文献+

重组葡激酶静脉溶栓疗法在老年急性心肌梗死治疗中的临床应用价值分析 被引量:3

下载PDF
导出
摘要 目的探讨对老年急性心肌梗死患者实施重组葡激酶静脉溶栓治疗的临床价值。方法选取老年急性心肌梗死患者53例,随即分为两组。其中,对照组26例,给予重组组织型纤溶酶原激活物静脉溶栓治疗;观察组27例,给予重组葡激酶静脉溶栓治疗。对两组患者的治疗效果及并发症情况进行比较。结果观察组患者血管再通情况明显优于对照组,并发出血情况明显低于对照组,两组比较差异具有统计学意义(P<0.05)。结论重组葡激酶用于治疗老年急性心肌梗死安全可靠,效果明显,值得临床推广。
作者 刘超龙
出处 《中国当代医药》 2012年第5期187-187,189,共2页 China Modern Medicine
  • 相关文献

参考文献4

二级参考文献32

  • 1刘斌,李淑梅,尚士芹,刘永生,鲁硕.主动脉气囊反搏术支持下对急性心肌梗塞并发泵功能衰竭患者的直接介入治疗[J].吉林大学学报(医学版),2004,30(5):775-777. 被引量:4
  • 2随云,张军,胡青.34096例急性心肌梗死病人的临床特征分析[J].中西医结合心脑血管病杂志,2005,3(7):640-641. 被引量:7
  • 3谭清武.老年冠心病367例临床分析[J].中国康复理论与实践,2006,12(6):473-474. 被引量:3
  • 4[2]Alpert JS, Becker RC. Mechanisms and management of cardiogenic shock [J]. Crit Care Clin, 1993, 9:205-218. 被引量:1
  • 5[3]Rafferty KM. Intra-aortic balloon pump issues from a management perspective[J]. Crit Care Nurs Clin North Am, 1996, 8:459-463. 被引量:1
  • 6[4]Sawada S. Dobuttamine echocardiograhy for detection of viable myocardium in ischemic cardiomyopathy[J].Echocardiograhy,2000,17:69-77. 被引量:1
  • 7兰军,潘伟彪,郭灼林,等.运用QRS记分法观察急诊PTCA对心肌梗塞面积的临床研究[J].中华实用医药杂志,2002,2(3):198-199. 被引量:1
  • 8[8]Kurisu S, Inoue I, Kawagoe T, et al. Effect of intra-aortic balloon pumping on left ventricular function in patients with persistent ST segment elevation after revascularization for acute myocardial infarction[J]. Circ J ,2003, 67:35-39. 被引量:1
  • 9[9]Moreno R, Garcia E. Early coronary angioplasty for acute myocardial infarction complicated by cardiogenic shock: have novel therapies led to better resuits[J]. J Invasive Cardiol, 2000,12:597-604. 被引量:1
  • 10Merlini PA,Bauer KA,Oltrona L,et al.Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction[J].J Am Coll Cardial,1995,25:203-209. 被引量:1

共引文献57

同被引文献24

  • 1Kowalski M,Brown G,Bieniasz M. Cloning and expression of a new recombinant thrombolytic and antithrombotic agent-a staphylokinase variant[J].Acta Biochimica Polonica,2009,(01):41-53. 被引量:1
  • 2Chen Y,Song G,Jiang F. Crystal structure of a staphylokinase:variant a model for reduced antigenicity[J].European Journal of Biochemistry,2002,(02):705-711. 被引量:1
  • 3Jin T,Bokarewa M,Foster T. Staphylococcus Aureus Resist Human Defensins by Production of Staphylokinase,a Novel Bacterial Evasion Mechanism[J].Journal of Immunology,2004,(02):1169-1176. 被引量:1
  • 4Grewal JS,Tsai JY,Khan SR. Oxalate-inducible AMBP gene and its regulatory mechanism in renal tubular epithelial cells[J].Biochemical Journal,2005,(Pt3):609-616. 被引量:1
  • 5Zhang Y,Gao Z,Zhang Z. Cloning,purification,crystallization and preliminary X-ray studies of human α1-microglobulin[J].Acta Crystallogr Sect F Struct Biol Cryst Co mmun,2012,(Pt 6):692-694. 被引量:1
  • 6Gase A,Hartmann M,Guhrs KH. Functional siguificance of NH2-and COOH-terminal regions of staphylokinase in plasminogen activation[J].Thrombosis and Haemostasis,1996,(05):55-60. 被引量:1
  • 7Hui J,Dai Y,Bian Y. Construction of novel bifunctional chimeric proteins possessing antitumor and thrombolytic activities[J].J Microbiol Bioteehnol,2012,(07):894-901. 被引量:1
  • 8Szemraj J,Zakrzeska A,Brown G. New derivative of staphylokinase SAK-RGD-K2-Hirul exerts thrombolytic effects in the arterial thrombosis model in rats[J].PHARMACOLOGICAL REPORTS,2011,(05):1169-1179. 被引量:1
  • 9Olsson MG,Allhorn M,Larsson J. UP-regulation of A1M/αl-microglobulin in skin by heme and reactive oxygen species gives protection from oxidative damage[J].PLoS One,2011,(11):e27505. 被引量:1
  • 10狄静芳,贺进田,徐瑞光,陈希,赵宝华.具有抗血小板聚集功能的新型葡激酶突变体的表达、纯化及性质[J].微生物学报,2008,48(9):1186-1191. 被引量:4

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部